Ocean Power Technologies (OPTT) stock jumps premarket as dilution vote nears
26 January 2026
1 min read

Ocean Power Technologies (OPTT) stock jumps premarket as dilution vote nears

NEW YORK, Jan 26, 2026, 05:11 (EST) — Premarket

  • OPTT shares surged in premarket action, building on their gains from Friday.
  • On Jan. 27, shareholders are set to vote on proposals that would raise the limits on share issuance and expand equity incentive programs.
  • The company’s approach to financing growth after securing a recent U.S. homeland security contract may depend heavily on this result.

Shares of Ocean Power Technologies Inc surged about 18% to $0.547 in premarket Monday, following an 8.1% rise last Friday that saw the stock close at $0.4649. 1

Investors are counting down to a shareholder vote that could greenlight the microcap maritime systems maker to issue additional stock. This kind of move usually raises red flags over dilution, as issuing new shares can erode the ownership percentages of existing shareholders.

Ocean Power is asking shareholders to approve a charter amendment that would boost its authorized common shares from 300 million to 400 million, the company said in its proxy statement. This move doesn’t dilute existing shares immediately but clears the way for potential equity raises in the future. 2

On the agenda, the company plans to expand its 2015 equity incentive scheme, increasing the share pool by 5 million to 32.28 million from 27.28 million. As of Dec. 1, there were fewer than 2 million shares left in that pool. 2

The annual meeting is set for Tuesday, Jan. 27, and will be conducted exclusively as a virtual webcast. Shareholders must register ahead of time by 10 a.m. ET on Monday. Within four business days after the meeting, the company intends to file a Form 8-K containing preliminary vote results. 2

Ocean Power is moving away from its wave-energy roots to concentrate on what it calls “intelligent maritime” — delivering power, communications, and uncrewed systems designed specifically for defense, security, and offshore energy sectors.

Earlier this month, it landed a contract worth more than $5 million to deploy and manage MERROWS-equipped PowerBuoy systems for a U.S. Coast Guard mission under the Department of Homeland Security. The project will also tie into Anduril’s surveillance and command-and-control systems. “This project marks another major step forward,” CEO Philipp Stratmann said in the release. 3

Ocean Power reported $0.4 million in revenue for the quarter ending Oct. 31, 2025, while posting a net loss of $10.8 million. The company highlighted a backlog close to $15 million and said a federal government shutdown delayed certain deliverables. 4

The risk is obvious. While companies argue that expanding share authorization and equity plan capacity offers flexibility, penny stock traders often interpret it as a warning sign of potential dilution—particularly if cash burn stays high and contract work drops.

Tuesday’s vote is the next big milestone. Investors are focused on the meeting outcome and the following SEC filing for insights into how aggressively Ocean Power plans to raise equity in the near term.

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Revolution Medicines stock dives in premarket after report Merck walked away from takeover talks
Previous Story

Revolution Medicines stock dives in premarket after report Merck walked away from takeover talks

Trilogy Metals (TMQ) stock jumps before the bell as Washington’s critical-minerals push hits headlines again
Next Story

Trilogy Metals (TMQ) stock jumps before the bell as Washington’s critical-minerals push hits headlines again

Go toTop